Market Research Report
Market Analysis on Molecular Diagnostics in Healthcare (pre-order)
|Published by||M14 Intelligence Research Pvt. Ltd.||Product code||919020|
Delivery time: Inquiry
|Market Analysis on Molecular Diagnostics in Healthcare (pre-order)|
|Published: December 2, 2019||Content info:||
M14 Intelligence expertise in precision medicine industry is a leverage of its multiple years of data-evaluation of emerging healthcare technologies. Our team of 2 consultants and 1 subject matter expert of molecular diagnostic technology has been tracking and evaluation the changing dynamics of the industry.
Electrophoresis, Mass spectroscopy, Flow Cytometry. Demand for Molecular diagnostics is analysed across different end users such as hospitals, laboratories, pharmaceuticals and biotechnology industries, clinical diagnostics, centres, universities and research organisations which is mentioned in this report.
Molecular Technologies that are analysed are Polymerase Chain Reactions (PCR), Hybridization, Sequencing (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Electrophoresis, Mass Spectroscopy, Flow Cytometry.
Leading companies and new entrants in the market are analysed for their revenue, product and service offerings.
The detailed survey on inorganic developments such as partnerships, mergers & acquisition, collaboration and organic developments are mentioned in this report.
Companies offering Molecular Diagnostics Technology mentioned in the report are: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic, Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated, Johnson and Johnson, GenMark diagnostics, Alere Inc., Analytik Jena, Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Biocartis Group NV, HiberGene Diagnostics, Celtic Molecular Diagnostics (Pty) Ltd., Laboratory Corporation of America Holdings, DNA Diagnostics Center, Elitechgroup, GE Healthcare, Inc., Genomic Health, Inc., Agendia NV, Luminex Corporation, Oxford Gene Technology, Savyon Diagnostics, Seegene Inc, Transgenomic Inc., Kaneka Eurogentec S.A, Milliporesigma, Myriad Genetics, Inc, Origene Technologies, Inc., Ortho Clinical Diagnostics, Perkinelmer Inc., Promega Corporation, Sorenson Genomics, LLC, Sysmex Inostics GmbH, Wuxi Nextcode, Grifols, Diasorin, 10X Genomics, Bristol-Myers Squibb, Foundation Medicine, HTG Molecular Diagnostics, Merck KGaA, Beckman Coulter Inc., GNA Biosolutions, Asuragen, Inc, AutoGenomics, MolecularMD. The list includes the leading players, new entrants and start-ups.